COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 115 filers reported holding COGENT BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 1.86 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,618,957 | -17.0% | 268,611 | +0.7% | 0.00% | – |
| Q2 2023 | $3,157,230 | +8.6% | 266,658 | -1.1% | 0.00% | – |
| Q1 2023 | $2,908,000 | +104092.0% | 269,493 | +11.6% | 0.00% | – |
| Q4 2022 | $2,791 | -99.9% | 241,420 | +5.5% | 0.00% | – |
| Q3 2022 | $3,414,000 | +6.4% | 228,842 | -35.7% | 0.00% | – |
| Q2 2022 | $3,210,000 | +161.8% | 355,908 | +117.3% | 0.00% | – |
| Q1 2022 | $1,226,000 | -34.0% | 163,801 | -24.3% | 0.00% | – |
| Q4 2021 | $1,857,000 | +14.3% | 216,445 | +12.0% | 0.00% | – |
| Q3 2021 | $1,625,000 | +18.4% | 193,325 | +14.2% | 0.00% | – |
| Q2 2021 | $1,373,000 | -37.0% | 169,221 | -31.8% | 0.00% | – |
| Q1 2021 | $2,179,000 | +188.6% | 248,168 | +269.2% | 0.00% | – |
| Q4 2020 | $755,000 | – | 67,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
| COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
| Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
| Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
| Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
| VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
| Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
| Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |